Characteristics and Factors Associated with the Clinical Forms of Lipoatrophy during Highly Active Antiretroviral Therapy in Ouagadougou, Burkina Faso

Guira, Oumar; Tiéno, H.; Yaméogo, Bertille; Diendéré, Arnaud Eric; Korsaga, N.; Sagna, Yempabou; Zoungrana, Lassané; Diallo, I; Traoré, René; Drabo, Joseph

doi:10.1177/2325957413503369

Cited by 2 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study from Burkina Faso also found male gender to be a factor in the development of LA. [29] Males physiologically have less body fat than females and thus may be more prone to the pathologic mechanisms inducing LA. [30][31][32] Other studies have found females to be more at greater risk for LA compared with males.…”

Section: Discussionmentioning

confidence: 99%

Lipoatrophy among patients on antiretroviral therapy in Lagos, Nigeria: Prevalence, pattern and association with cardiovascular risk factors

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Lipoatrophy among patients on antiretroviral therapy in Lagos, Nigeria: Prevalence, pattern and association with cardiovascular risk factors

et al. 2015

View full text Add to dashboard Cite

show abstract

“… Cross-sectional and comparative Brazil Siqueira LR et al, 2021 7 Lipodystrophy negatively affects the self-esteem of HIV infected people and this made it difficult to adhere to ART. Cross-sectional Burkina Faso Guira O et al, 2014 31 Facial lipoatrophy contributes more to stigma Cross-sectional Spain Méndez ES et al, 2015 32 About 27% of participants, who feared lipodystrophy, had poor adherence to treatment Single-site cross-sectional Switzerland Verolet CM et al, 2015 33 Lipodystrophy was associated with a poor quality of life among HIV AIDS patients on HAART. …”

Section: Forms Of Lipodystrophy Syndromesmentioning

confidence: 99%

Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review

Lamesa

2024

HIV

View full text Add to dashboard Cite

Lipodystrophy syndrome is a medical condition characterized by the absence of adipose tissue without any underlying starvation or macromolecule breakdown. In HIV AIDS patients, the use of highly active antiretroviral therapy (HAART) can lead to an acquired form of lipodystrophy, with a prevalence ranging from 10% to 83% among HIV AIDS patients. It was aimed to review the current understanding of biological depiction and challenges related to lipodystrophy in AIDS patients. Relevant articles published in the English language were searched in PubMed, Google Scholar, and Google. Keywords used for the search were: lipodystrophy, lipodystrophy and HIV, ART and lipodystrophy, HIV treatment, metabolic syndrome and HIV. Articles with full abstract information were read for those that met the objective criteria of the review, then full text of the articles was accessed and used. It was revealed by the literature that patients who developed lipodystrophy are characterized by insulin abnormality, obesity, diabetes mellitus, dyslipidemia, fatty liver disease, and ovarian dysfunction. Anthropometric measurements have been known to change significantly with lipodystrophy. HIV patients suffering from hepatitis C virus, hepatitis B virus, who take a protease inhibitor, are changing treatment or duration of treatment, and are women are the common risk factors for lipodystrophy. The metabolic syndrome seen in HIV patients associated with lipodystrophy can further be complicated to different adverse health effects and can result in increased morbidity and mortality rate if not treated. Existing studies have successfully identified several challenges faced by HIV AIDS patients due to lipodystrophy, including low self-esteem, compromised quality of life, and poor treatment adherence. However, it is crucial to acknowledge that there may be numerous other challenges that have yet to be discovered, emphasizing the need for further studies. It is recommended that managing dyslipidemia, treating diabetes mellitus, modifying lifestyle, and improving the anthropometric measurements have crucial roles to halt further complications associated with lipodystrophy.

show abstract

Characteristics and Factors Associated with the Clinical Forms of Lipoatrophy during Highly Active Antiretroviral Therapy in Ouagadougou, Burkina Faso

Abstract: Prevention of lipoatrophy associated with HAART requires the exclusion of modifiable risk factors that we identified.

Cited by 2 publications

References 14 publications

Lipoatrophy among patients on antiretroviral therapy in Lagos, Nigeria: Prevalence, pattern and association with cardiovascular risk factors

Lipoatrophy among patients on antiretroviral therapy in Lagos, Nigeria: Prevalence, pattern and association with cardiovascular risk factors

Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review

Contact Info

Product

Resources

About